Metropolitan Digital

Men's Weekly


.

Backlash against Johnson Johnson's COVID-19 vaccine is real and risky – here's how to make its rollout a success

  • Written by Tinglong Dai, Associate Professor of Operations Management & Business Analytics, Johns Hopkins Carey Business School, Johns Hopkins University School of Nursing
Backlash against Johnson Johnson's COVID-19 vaccine is real and risky – here's how to make its rollout a successThe concern is about more than one shot vs. two.Michael Ciaglo/Getty Images

More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out.

The Johnson & Johnson vaccine has been hailed...

Read more: Backlash against Johnson Johnson's COVID-19 vaccine is real and risky – here's how to make its...

More Articles ...

  1. Support for QAnon is hard to measure – and polls may overestimate it
  2. Support for Biden's $1.9 trillion coronavirus relief package may not be as broad as it seems – it's all a matter of perspective
  3. Women used to dominate the beer industry – until the witch accusations started pouring in
  4. Going forth with standardized tests may cause more problems than it solves
  5. Fungal microbiome: Whether mice get fatter or thinner depends on the fungi that live in their gut
  6. Why white supremacists and QAnon enthusiasts are obsessed – but very wrong – about the Byzantine Empire
  7. The science behind frozen wind turbines – and how to keep them spinning through the winter
  8. January warm spells, March freezes: How plants manage the shift from winter to spring
  9. Revisiting reparations: Is it time for the US to pay its debt for the legacy of slavery?
  10. What the policing response to the KKK in the 1960s can teach about dismantling white supremacist groups today
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more